Suppr超能文献

肺原位腺癌和微浸润性腺癌的独特临床病理特征:一项回顾性研究。

Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.

机构信息

Department of General Thoracic Surgery, Saitama Medical University International Medical Center, Saitama, Japan.

Department of Pathology, Saitama Cardiovascular and Respiratory Center, Saitama, Japan; Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.

出版信息

Lung Cancer. 2019 Mar;129:16-21. doi: 10.1016/j.lungcan.2018.12.020. Epub 2018 Dec 19.

Abstract

OBJECTIVES

The aim of this study was to investigate distinguishing clinicopathological features, in addition to histological invasiveness, in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) of the lung.

MATERIALS AND METHODS

Patients with lung adenocarcinoma who underwent surgery at our hospital between 2007 and 2014 were reviewed, focusing on computed tomography (CT) images, operative procedures and clinical outcomes, histopathology, Ki-67 immunostaining, and EGFR-mutation status. EGFR mutations were examined using a peptide nucleic acid-locked nucleic acid PCR clamp method. Group comparisons were investigated by Mann-Whitney U or Fisher's exact tests.

RESULTS

Of 629 patients with lung adenocarcinoma who underwent surgery, 91 (14%) of 103 AIS (n = 34) or MIA (n = 69) tumors were reviewed. The ratio of male to female patients with MIA compared to AIS was significantly higher (p <  0.02). Of 103 tumors, 99 (96%) were non-mucinous. By CT, 74% of AIS appeared as pure ground-glass nodules and 75% of MIAs as part-solid ground-glass nodules. Pathological tumor diameters and Ki-67 labeling index (LI) values were significantly greater for MIAs compared to AIS (p <  0.001 for both). A Ki-67 LI of ≥2.8% indicated the presence of an MIA rather than an AIS. EGFR mutations were more frequently detected in MIAs (33/69, 48%) than AIS (9/34, 26%; p =  0.055). The ratio of exon 19 deletions to exon 21 missense mutations in MIAs tended to be higher than those in AIS (p =  0.06). Patients did not experience a local recurrence or metastasis after AIS and MIAs were removed by wedge resection, segmentectomy or lobectomy. Five-year recurrence-free survival rates were 100%.

CONCLUSION

Despite similar surgical outcomes for AIS and MIAs, we found differences in terms of gender, tumor diameters, CT findings, Ki-67 LI and a subset of EGFR mutations, highlighting the validity of classifying the two subtypes.

摘要

目的

本研究旨在探讨肺腺癌原位癌(AIS)和微浸润腺癌(MIA)的临床病理特征,除了组织学侵袭性。

材料与方法

回顾 2007 年至 2014 年在我院行手术治疗的肺腺癌患者,重点分析 CT 图像、手术方式和临床结果、组织病理学、Ki-67 免疫组化和 EGFR 突变状态。采用肽核酸锁核酸 PCR 夹法检测 EGFR 突变。采用 Mann-Whitney U 或 Fisher 确切概率法进行组间比较。

结果

在 629 例接受手术治疗的肺腺癌患者中,对 103 例 AIS(n=34)或 MIA(n=69)肿瘤的 91 例(14%)进行了回顾。与 AIS 相比,MIA 患者中男性与女性的比例明显更高(p<0.02)。103 例肿瘤中,99 例(96%)为非黏液性。在 CT 上,74%的 AIS 表现为单纯磨玻璃结节,75%的 MIA 表现为部分实性磨玻璃结节。与 AIS 相比,MIA 的肿瘤直径和 Ki-67 标记指数(LI)值明显更大(p<0.001)。Ki-67 LI≥2.8%提示存在 MIA 而不是 AIS。MIA 中 EGFR 突变的检出率明显高于 AIS(33/69,48%比 9/34,26%;p=0.055)。MIA 中 exon19 缺失与 exon21 错义突变的比例倾向于高于 AIS(p=0.06)。AIS 和 MIA 楔形切除、节段切除或肺叶切除后,患者无局部复发或转移。5 年无复发生存率为 100%。

结论

尽管 AIS 和 MIA 的手术结果相似,但我们发现了在性别、肿瘤直径、CT 表现、Ki-67 LI 和 EGFR 突变亚群方面的差异,这凸显了对这两种亚型进行分类的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验